Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Single-nucleus RNA sequencing reveals transcriptional heterogeneity in the blastema of favorable-histology Wilms tumor
Mike Adam, Keri A. Drake, Naomi Pode-Shakked, Katherine VandenHeuvel, S. Steven Potter, James Geller
Mike Adam, Keri A. Drake, Naomi Pode-Shakked, Katherine VandenHeuvel, S. Steven Potter, James Geller
View: Text | PDF
Research Article Development Nephrology Oncology

Single-nucleus RNA sequencing reveals transcriptional heterogeneity in the blastema of favorable-histology Wilms tumor

  • Text
  • PDF
Abstract

While Wilms tumors commonly arise from renal precursor cells and maintain features of the developing kidney, recent studies have demonstrated substantial genetic, histologic, and molecular heterogeneity. To further investigate tumor variability as well as unifying features in tumor biology, we performed single-nucleus RNA sequencing (snRNA-seq) on treatment-naive, favorable-histology Wilms tumors utilizing a reference atlas established from tumor-adjacent kidney samples and fetal kidney. Transcriptional profiles of blastemal, stromal, and epithelial components were correlated with tumor histology and demonstrated developmental-lineage plasticity, with PAX2 and PAX8 expression normally restricted to the nephron lineage of the fetal kidney found to be expressed in tumor stroma, as well as the stromal marker POSTN identified in tumor blastema. Further analyses of the blastema show shared transcriptional features with the differentiation trajectory of “uninduced” to “early differentiating” fetal nephron progenitor cells as well as aberrant expression of stromal signatures. A number of pathways from fetal nephron progenitors were maintained in the blastema, including regulation of stem cell maintenance and axonogenesis, whereas other pathways appear enriched in specific tumor samples, demonstrating the ability of snRNA-seq to identify both unifying transcriptional signatures and uncover distinct molecular targets in signaling pathways and/or biological drivers of Wilms tumorigenesis.

Authors

Mike Adam, Keri A. Drake, Naomi Pode-Shakked, Katherine VandenHeuvel, S. Steven Potter, James Geller

×

Figure 3

Blastemal, stromal, and epithelial components from favorable-histology Wilms tumor show multilineage plasticity.

Options: View larger image (or click on image) Download as PowerPoint
Blastemal, stromal, and epithelial components from favorable-histology W...
(A) The expression pattern of selected genes from the snRNA-seq dataset was evaluated across the NPC/blastema, stromal, and epithelial components of human fetal kidney and tumor snRNA-seq data. In the fetal kidney, several genes show cell-type-specific expression patterns, with SIX2 and WT1 primarily expressed in NPCs, PAX2 and PAX8 expressed in the nephron lineage (i.e., NPCs and differentiating epithelial cells, but not the interstium/stroma), and PDGFRA, PDGFRB, and POSTN expressed in the interstitium. Tumor snRNA-seq shows misexpression of several lineage-specific genes, including SIX2 expression in epithelial cells of T1 and T5, POSTN expression in the blastema of T3, T5, and T7, and PAX8 expression in the interstitium of T4 with both PAX2 and PAX8 in T8. (B–M) Representative images of immunofluorescence validation confirms expression of the selected markers in tumor samples, with costaining showing misexpression of a number of lineage-specific markers. Specifically, SIX2-expressing cells appear to show coexpression of PDGFRα (B, arrows) and POSTN (C and D, arrows). Additionally, PAX2 appears coexpressed with PDGFRα in some regions of T8 (L, arrow). Representative images of tumors from at least 2 separately stained sections are shown at ×10 magnification. Scale bars: 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts